Equitable Holdings’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
21,572
+1,714
| +9% | +$120K | 0.01% | 670 |
|
|
2025
Q1 | $1.46M | Buy |
19,858
+805
| +4% | +$59.2K | 0.01% | 602 |
|
|
2024
Q4 | $1.25M | Buy |
19,053
+11,001
| +137% | +$721K | 0.01% | 614 |
|
|
2024
Q3 | $627K | Buy |
8,052
+1,969
| +32% | +$153K | 0.01% | 808 |
|
|
2024
Q2 | $474K | Buy |
6,083
+1,322
| +28% | +$103K | 0.01% | 847 |
|
|
2024
Q1 | $323K | Buy |
4,761
+394
| +9% | +$26.7K | ﹤0.01% | 939 |
|
|
2023
Q4 | $294K | Sell |
4,367
-263
| -6% | -$17.7K | ﹤0.01% | 945 |
|
|
2023
Q3 | $314K | Buy |
4,630
+438
| +10% | +$29.7K | ﹤0.01% | 857 |
|
|
2023
Q2 | $300K | Sell |
4,192
-19
| -0.5% | -$1.36K | ﹤0.01% | 847 |
|
|
2023
Q1 | $292K | Buy |
4,211
+302
| +8% | +$21K | ﹤0.01% | 806 |
|
|
2022
Q4 | $265K | Sell |
3,909
-66
| -2% | -$4.48K | ﹤0.01% | 769 |
|
|
2022
Q3 | $218K | Sell |
3,975
-17
| -0.4% | -$932 | ﹤0.01% | 784 |
|
|
2022
Q2 | $264K | Buy |
3,992
+149
| +4% | +$9.85K | 0.01% | 732 |
|
|
2022
Q1 | $255K | Buy |
3,843
+48
| +1% | +$3.19K | ﹤0.01% | 772 |
|
|
2021
Q4 | $221K | Sell |
3,795
-40
| -1% | -$2.33K | ﹤0.01% | 798 |
|
|
2021
Q3 | $230K | Buy |
+3,835
| New | +$230K | ﹤0.01% | 762 |
|